Abstract:Background Systemically administered dexmedetomidine (DEX), a selective α2 adrenergic receptor (α2-AR) agonists, produces analgesia and sedation. Peripherally restricted α2-AR antagonist could block the analgesic effect of systemic DEX on neuropathic pain, with no effect on sedation, indicating peripheral analgesic effect of DEX. Tetrodotoxin-resistant (TTX-R) sodium channel Na v 1.8 play important roles in the conduction of nociceptive sensation. Both α2-AR and Nav1.8 are found in small nociceptive DRG neurons. We, therefore, investigated the effects of DEX on the Na v 1.8 currents in acutely dissociated small-diameter DRG neurons. Results Whole-cell patch-clamp recordings demonstrated that DEX concentration-dependently suppressed TTX-R Na v 1.8 currents in small-diameter lumbar DRG neurons. DEX also shifted the steady-state inactivation curves of Na v 1.8 in a hyperpolarizing direction and increased the threshold of action potential and decrease electrical and chemical stimuli-evoked firings in small-diameter DRG neurons. The α2-AR antagonist yohimbine or α2 A -AR antagonist BRL44408 but not α2 B -AR antagonist imiloxan blocked the inhibition of Na v 1.8 currents by DEX. Immunohistochemistry results showed that Na v 1.8 was predominantly expressed in peripherin-positive small-diameter DRG neurons, and some of them were α2 A -AR-positive ones. Our electrophysiological recordings also demonstrated that DEX-induced inhibition of Na v 1.8 currents was prevented by intracellular application of G-protein inhibitor GDPβ-s or G i/o proteins inhibitor pertussis toxin (PTX), and bath application of adenylate cyclase (AC) activator forskolin or membrane-permeable cAMP analogue 8-Bromo-cAMP (8-Br-cAMP). PKA inhibitor Rp-cAMP could mimic DEX-induced inhibition of Na v 1.8 currents. Conclusions We established a functional link between α2-AR and Na v 1.8 in primary sensory neurons utilizing the G i/o /AC/cAMP/PKA pathway, which probably mediating peripheral analgesia of DEX.

Growth Differentiation Factor-15 Produces Analgesia by Inhibiting Tetrodotoxin-Resistant Nav1.8 Sodium Channel Activity in Rat Primary Sensory Neurons

Wound-healing Growth Factor, Basic FGF, Induces Erk1/2-dependent Mechanical Hyperalgesia

Axotomy-Induced Up-Regulation of Tumor Necrosis Factor-Alpha in the Dorsal Root Ganglia

Glial cell line-derived neurotrophic factor contributes to delayed inflammatory hyperalgesia in adjuvant rat pain model.

Growth differentiation factor-15 promotes glutamate release in medial prefrontal cortex of mice through upregulation of T-type calcium channels

Inhibition of NF-kappaB Prevents Mechanical Allodynia Induced by Spinal Ventral Root Transection and Suppresses the Re-Expression of Nav1.3 in DRG Neurons in Vivo and in Vitro.

Upregulation of Nav1.3 Channel Induced by Rrtnf in Cultured Adult Rat DRG Neurons Via P38 MAPK and JNK Pathways.

EFFECT OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR ON RAT NEUROPATHIC PAIN

Enhanced Activities Of Delta Subunit-Containing Gaba(A) Receptors Blocked Spinal Long-Term Potentiation And Attenuated Formalin-Induced Spontaneous Pain

Decreased GDNF Mrna Expression in Dorsal Spinal Cord of Unilateral Arthritic Rat.

Inhibition of Endogenous NGF Degradation Induces Mechanical Allodynia and Thermal Hyperalgesia in Rats

GDF15 regulates Kv2.1-mediated outward K+ current through the Akt/mTOR signalling pathway in rat cerebellar granule cells.

GDF-15 enhances intracellular Ca2+ by increasing Cav1.3 expression in rat cerebellar granule neurons.

Functional Upregulation of Nav1.8 Sodium Channels on the Membrane of Dorsal Root Ganglia Neurons Contributes to the Development of Cancer-Induced Bone Pain

Fibroblast Growth Factor 13 Stabilizes Microtubules to Promote Na+ Channel Function in Nociceptive DRG Neurons and Modulates Inflammatory Pain.

The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund's adjuvant

TNF-α contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury

Nerve Growth Factor/Tyrosine Kinase A Receptor Pathway Enhances Analgesia in an Experimental Mouse Model of Bone Cancer Pain by Increasing Membrane Levels of Δ-Opioid Receptors.

Nerve growth factor rapidly prolongs the action potential of mature sensory ganglion neurons in culture, and this effect requires activation of Gs-coupled excitatory kappa-opioid receptors on these cells

Dexmedetomidine inhibits Tetrodotoxin-resistant Na v 1.8 sodium channel activity through G i/o -dependent pathway in rat dorsal root ganglion neurons

The impact of N-cadherin-β-catenin signaling on the analgesic effects of glial cell-derived neurotrophic factor in neuropathic pain